Maximum quantity allowed is 999
Please select the quantity
CAS RN: 145525-41-3 | Product Number: M3177
Mitiglinide Calcium
×
![]()
×
Purity:
Synonyms:
- (αS,3aR,7aS)-Octahydro-γ-oxo-α-(phenylmethyl)-2H-isoindole-2-butanoic Acid Calcium Salt
Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 100MG |
$97.00
|
19 | 8 |
| 500MG |
$340.00
|
≥20 | 14 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | M3177 |
| Molecular Formula / Molecular Weight | C__3__8H__4__8CaN__2O__6 = 668.89 |
| Physical State (20 deg.C) | Solid |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Moisture Sensitive |
| CAS RN | 145525-41-3 |
| Reaxys Registry Number | 8027952 |
| Merck Index (14) | 6211 |
| MDL Number | MFCD09955408 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Chelometric Titration) | min. 97.0 % |
| Specific rotation [a]20/D | +5.0 to +9.0 deg(C=1, MeOH(calcd.on anh.substance)) |
| Water | 4.5 to 6.0 % |
Properties (reference)
| Melting Point | 185 °C |
| Specific Rotation | 5.5° (C=1,MeOH) |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2933.99-000 |
Application
Mitiglinide Calcium: A Fast-Acting Insulin-Releasing Agent
Mitiglinide calcium (KAD-1229; s 21403) is a glitinide class non-sulfonylurea insulinotropic agent with rapid onset. More rapidly than that of sulfonylurea antidiabetics, mitiglinide inhibits ATP-gated K+ channels and thereby causes depolarization of the B-cell membrane. The depolarization leads to activation of voltage-dependent Ca channels and Ca2+ influx into the B-cell, and eventually increases insulin release. For your reference, [O0471] is a synthetic intermediate of mitiglinide. (The product is for research purpose only.)
References
- Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
- The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
- Effects of mitiglinide (s 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel
- Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus (a review)
- Simple, sensitive, and rapid LC-ESI-MS method for quantification of mitiglinide in human urine
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number
Incorrect Lot Number is entered
The requested analytical chart is not available. Sorry for the inconvenience.